OVERLAND PARK, KS--(Marketwired - Dec 10, 2013) - Durrie Vision, an internationally recognized refractive surgery practice specializing in laser vision correction and refractive surgery research, today announced the appointment of Harry S. Campbell as its Chief Executive Officer. This is the first time the business will be led by a non-physician since its founding in 1991.

Campbell brings significant senior management experience and a track record of success to this new position leading Durrie Vision. He has held executive leadership positions in two Fortune 500 companies, co-owned an award-winning small business in Kansas City, led an internet start-up and was founding member of the Wal-Mart/P&G Customer Team.

"It's an honor and a privilege to join the Durrie Vision team," said Campbell. "Durrie Vision is known not only locally as a leader in the field of vision correction, but the experts here are also recognized worldwide. I can't imagine a more exciting opportunity."

Harry Campbell has led exceptional people and delivered remarkable results in organizations of 25 to 3,500 employees across various industries. He is known as an identifier, developer and motivator of distinctive talent. He also speaks to companies and organizations across the country using the principles outlined in the book he authored, Get-Real Leadership.

"Harry brings significant experience and expertise and will further develop the superior talent that already exists within the Durrie Vision team," explained Dr. Daniel Durrie, founder of Durrie Vision. "Appointing Harry Campbell as CEO allows me more time to focus on patient care, research and my work within the refractive surgery industry."

Dr. Durrie currently serves as the Chief Physician Officer for Alphaeon, a lifestyle medicine organization based in California focused on innovation in the lifestyle medicine industry.

"The Durrie Vision leadership team had specific benchmarks and criteria for our new CEO," said Dr. Jason Stahl, refractive surgeon. "We were strategic and worked diligently to ensure the leader we chose could build on our success and take full advantage of the opportunities that lie ahead for Durrie Vision. Dr. Durrie is handing over a company that is solid and well-positioned for long-term growth."

Dr. Durrie continued, "Harry is a natural cultural fit with Durrie Vision. He is recognized for strong and energetic leadership, strategic vision and driving growth and innovation. This is a significant step forward for our company."

About Harry S. Campbell
Harry Campbell has more than two decades of success as a leader and/or owner of companies ranging in size from startups to Fortune 500 giants.

Recently, Harry led the Consumer Markets division at Embarq, a spin-off from Sprint. Purchased by CenturyTel and now known as CenturyLink, Embarq was a Fortune 500, NYSE-traded telecom company with annual revenue of $6 billion. As president of the Consumer Markets division, Harry was responsible for nearly half of Embarq's annual revenue and an organization of 3,000 employees. His group provided marketing, sales, service and operational support for a full line of communication and entertainment services to 4 million residential customers in 18 states.

Harry holds a bachelor's degree in East Asian History and Economics from Vanderbilt University and an MBA with a concentration in marketing from Indiana University's Kelley Graduate School of Business.

About Daniel S. Durrie, MD
Daniel Durrie, MD is a board certified Ophthalmologist and an internationally recognized refractive surgeon with more than 35 years of experience in corneal and refractive surgery. He has dedicated his career to pioneering procedures to correct nearsightedness, farsightedness, astigmatism and presbyopia.

Dr. Durrie has received numerous prestigious awards and honors from the International Society of Refractive Surgery. He was named one of the "Top Ten Refractive Surgeons in America by Ophthalmology Times and one of the "Fifty Most Influential Ophthalmologists in the World" by Cataract and Refractive Surgery Today.

In addition to his role as Chief Physician Officer for Alphaeon, Dr. Durrie serves as a clinical professor and Director of Refractive Surgery Services at the University of Kansas Medical Center. His research center in Kansas City is one of the few in the country selected to conduct FDA clinical trials.

About Jason E. Stahl, MD
Dr. Stahl, recently recognized as one of America's top ophthalmologists, is a highly skilled refractive surgeon, whose experience spans over a decade.

A board certified ophthalmologist and member of the American Board of Ophthalmology, Dr. Stahl specializes in refractive lens and laser vision correction procedures that correct nearsightedness, farsightedness, astigmatism and presbyopia.

He was named a "Leader and Innovator" in the field of refractive surgery and has participated as a research investigator in numerous FDA clinical trials. Dr. Stahl's research data and opinions have been published in many medical journals.

About Jason P. Brinton, MD
Dr. Jason Brinton, specializes in both refractive lens exchange and laser vision correction procedures to correct nearsightedness, farsightedness, astigmatism and presbyopia.

Dr. Brinton is a board certified, third generation Ophthalmologist and member of the American Board of Ophthalmology. Dr. Brinton's research data has been published in many medical journals and publications.

He earned his medical doctorate from Harvard Medical School and completed his fellowship in cornea and refractive surgery under joint appointment with Durrie Vision and The University of Kansas.

To view the original source of this press release, click here: http://www.durrievision.com/durrie-vision-news/durrie-vision-announces-new-chief-executive-officer/.

Contact Information:

Media Contact
Angie Beerup